about
Serum fatty acid profile in psoriasis and its comorbidity.Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.Treatment options for nonalcoholic steatohepatitis - a safety evaluation.G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux.Nutrition, inflammation and liver-spleen axis.Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics.Endoplasmic Reticulum Stress Inducer Tunicamycin Alters Hepatic Energy Homeostasis in Mice.A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice.Targeting Sirt1 in a rat model of high-fat diet-induced non-alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol.Non-alcoholic Fatty Liver Disease: A Clinical Update.Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3–5 October 2016Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
P2860
Q33840850-7ABEF9EB-B17C-4388-9925-A4B6C812434CQ37721436-F5ABB041-C4A9-41A4-818B-7A6596CEFF83Q38675911-CE4CD72D-B750-4C90-93CB-F46DC15216E1Q38713765-144EC666-5E8A-4947-BEF9-03DBF61F8C62Q39395189-FE6245B0-8026-47D6-932D-4E4D99CD4CFDQ40086170-D2639EED-5F1A-4C91-A7B9-C3DDC338AA36Q41552560-EF1F6BF8-0AA8-41AE-B77E-A0E4A84C4F00Q41573763-A3C9193E-C1D4-4C54-8BD5-4733E6DC926DQ42379258-6FA066D4-7B4C-44C2-858D-0B20C73996B5Q42730581-6B38722B-16B0-40DD-A16A-0202B76998B5Q45691213-EC1F6CBE-BFC9-4B8D-808B-37DCB4929635Q47100244-4A487E84-C2AC-4FC8-B582-AD8F490EAC7CQ49337769-D298AD5A-D3B5-4131-8B63-66F0A0727A78Q51102949-D27150AD-246D-4FE9-8D08-A0CE7656B6DEQ55501328-F3584440-3693-4C14-8B5F-C799B5102BAEQ57249336-58BDDA27-3778-447B-A21B-F1742DFC01E3Q58747079-159C33A0-69E5-440B-B92A-0F0248E74938
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pathophysiology of Non Alcoholic Fatty Liver Disease
@ast
Pathophysiology of Non Alcoholic Fatty Liver Disease
@en
Pathophysiology of Non Alcoholic Fatty Liver Disease
@nl
type
label
Pathophysiology of Non Alcoholic Fatty Liver Disease
@ast
Pathophysiology of Non Alcoholic Fatty Liver Disease
@en
Pathophysiology of Non Alcoholic Fatty Liver Disease
@nl
prefLabel
Pathophysiology of Non Alcoholic Fatty Liver Disease
@ast
Pathophysiology of Non Alcoholic Fatty Liver Disease
@en
Pathophysiology of Non Alcoholic Fatty Liver Disease
@nl
P2093
P2860
P50
P921
P356
P1476
Pathophysiology of Non Alcoholic Fatty Liver Disease
@en
P2093
Eleni Rebelos
Gianluca Svegliati-Baroni
Piergiorgio Messa
Salvatore Petta
P2860
P356
10.3390/IJMS17122082
P407
P5008
P577
2016-12-11T00:00:00Z